Abstract:Background: The programmed cell death ligand 1/programmed cell death receptor 1 (PD-L1/PD-1) Immune Checkpoint is an important modulator of the immune response. Overexpression of the receptor and its ligands is involved in immunosuppression and the failure of an immune response against tumor cells. PD-1/PD-L1 overexpression in oral squamous cell carcinoma (OSCC) compared to healthy oral mucosa (NOM) has already been demonstrated. However, little is known about its expression in oral precancerous lesions like oral leukoplakia (OLP). The aim of the study was to investigate whether an increased expression of PD-1/PD-L1 already exists in OLP and whether it is associated with malignant transformation. Material and Methods: PD-1 and PD-L1 expression was immunohistologically analyzed separately in the epithelium (E) and the subepithelium (S) of OLP that had undergone malignant transformation within 5 years (T-OLP), in OLP without malignant transformation (N-OLP), in corresponding OSCC and in NOM. Additionally, RT-qPCR analysis for PD-L1 expression was done in the entire tissues. Additionally, the association between overexpression and malignant transformation, dysplasia and inflammation were examined. Results: Compared to N-OLP, there were increased levels of PD-1 protein in the epithelial and subepithelial layers of T-OLP (pE = 0.001; pS = 0.005). There was no significant difference in PD-L1 mRNA expression between T-OLP and N-OLP (p = 0.128), but the fold-change increase between these groups was significant (Relative Quantification (RQ) = 3.1). In contrast to N-OLP, the PD-L1 protein levels were significantly increased in the epithelial layers of T-OLP (p = 0.007), but not in its subepithelial layers (p = 0.25). Importantly, increased PD-L1 levels were significantly associated to malignant transformation within 5 years. Conclusion: Increased levels of PD-1 and PD-L1 are related to malignant transformation in OLP and may represent a promising prognostic indicator to determine the risk of malignant progression of OLP. Increased PD-L1 levels might establish an immunosuppressive microenvironment, which could favor immune escape and thereby contribute to malignant transformation. Hence, checkpoint inhibitors could counteract tumor development in OLP and may serve as efficient therapeutic strategy in patients with high-risk precancerous lesions.

Immunohistochemical Detection of Aurora A and ERK Pathway in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Application of Bioinformatics to Optimization of Serum Proteome in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma

Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia

Expression of DNA Doublestrand Repair Proteins in Oral Leukoplakia and the Risk of Malignant Transformation

Expression Patterns of Cancer Stem Cell Markers Aldh1 and Cd133 Correlate with A High Risk of Malignant Transformation of Oral Leukoplakia

Risk Factors Associated with Malignant Transformation in Patients with Oral Leukoplakia in a Chinese Population: A Retrospective Study.

Expression of Cancer Stem Cell Markers ALDH1 and Bmi1 in Oral Erythroplakia and the Risk of Oral Cancer.

Oral Cancer Development in Patients with Leukoplakia - Clinicopathological Factors Affecting Outcome

Multiple Kallikrein (KLK 5, 7, 8, and 10) Expression in Squamous Cell Carcinoma of the Oral Cavity.

Expression of Podoplanin and ABCG2 in Oral Erythroplakia Correlate with Oral Cancer Development

Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach

Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia

Expression of Osteopontin in Oral Mucosal Epithelium in Patients with Oral Leukoplakia

Demographic study of 366 cases of oral leukoplakia and immunohistochemical analysis - An institutional study

Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity.

Significance of Phosphoinositol Metabolism by DNA Methylation May Contribute in Oral Leukoplakia Carcinogenesis

ORAL LEUKOPLAKIA, THE FIRST CLINICAL FINDING OF ORAL SQUAMOUS CELL CARCINOMA (OSCC): A CASE REPORT

[A Retrospective Analysis on the Malignant Transformation Rate, Time and Risk Factors of Oral Leukoplakia].

Significance of ErbB4 and Bcl-2 in oral squamous cell carcinoma